Female BALB/c mice (8-wk-old; Janvier) were immunized intraperitoneally with a priming dose of 20 µg purified AID protein (produced in Escherichia coli, as described in [1] ) in complete Freund's adjuvant (Sigma-Aldrich), followed by 2 booster immunizations at 3-wk intervals with 10 µg AID in incomplete Freund's adjuvant. 3 d before fusion, the mouse with the highest antigen-specific antibody titer received a final boost of 10 µg of AID protein in PBS. Hybridomas were generated using standard protocols. Primary hybridomas supernatants were screened by ELISA for anti-AID antibody production, and positive wells were cloned by limiting dilution in 60-well Terazaki plates in growing medium supplemented with 2.5% hybridokine (Interchim). Wells positive after two rounds of cloning were expanded for further analysis. For large-scale mAb production, hybridoma cells were cultured in RPMI, 5% FCS supplemented with the OptiMAb Monoclonal Antibody Production Enhancer (Invitrogen) according to the manufacturer's instructions. A mixture of two selected clones, 4.26.1 (IgG2a) and 4.18.1 (IgG2b), was used in this study (Fig. S2 ).
